Suppr超能文献

多学科视角下儿童肥胖早期评估中的生物标志物与机制——一篇叙述性综述

Biomarkers and Mechanisms in the Early Assessment of Childhood Obesity from a Multidisciplinary Perspective-A Narrative Review.

作者信息

Mindru Dana Elena, Bozomitu Laura Iulia, Păduraru Dana Teodora Anton, Țarcă Elena, Curici Antoanela, Elkan Eva Maria, Butnariu Lăcrămioara Ionela, Moraru Dan Cristian, Diaconescu Cosmin, Luca Alina Costina

机构信息

Department of Mother and Child Medicine, Faculty of Medicine, University of Medicine and Pharmacy "Gr.T.Popa", 700115 Iasi, Romania.

Emergency Clinical Hospital for Children "Sfanta Maria" Iasi, 700309 Iasi, Romania.

出版信息

Medicina (Kaunas). 2025 Mar 27;61(4):607. doi: 10.3390/medicina61040607.

Abstract

Obesity has been the subject of research focused on preventive policies among the young population due to epidemiological studies which have shown devastating figures in recent years in terms of the incidence and prevalence of this condition. A number of previously known biomarkers have proven useful in the early diagnosis of complications associated with obesity, while others remain in the study stage. The intestinal microbiota are also relevant in the secondary prevention of obesity complications, another area that has turned into a hot topic of current research. The primary goal of this review is to highlight markers and mechanisms that can enhance specialists' understanding of obesity assessment and its systemic complications. Salivary markers have been proven useful in the evaluation of obesity, with the advantage of being low-cost and easy to sample. Another interesting topic is the role of the renin-angiotensin and the kallikrein-kinin systems in obesity-related systemic complications. One well-known fact is the connection between obesity and high blood pressure, which is closely related to these systems. This paper also explores the link between gut microbiota and adiposity, particularly the potential of the Firmicutes/Bacteroidetes ratio as a useful biomarker.

摘要

由于流行病学研究表明近年来肥胖症的发病率和患病率数据惊人,肥胖已成为针对年轻人群预防政策的研究主题。一些先前已知的生物标志物已被证明在肥胖相关并发症的早期诊断中有用,而其他一些仍处于研究阶段。肠道微生物群在肥胖症并发症的二级预防中也具有相关性,这一领域已成为当前研究的热点话题。本综述的主要目的是突出那些能够增强专家对肥胖评估及其全身并发症理解的标志物和机制。唾液标志物已被证明在肥胖评估中有用,其优点是成本低且易于采样。另一个有趣的话题是肾素 - 血管紧张素和激肽释放酶 - 激肽系统在肥胖相关全身并发症中的作用。一个众所周知的事实是肥胖与高血压之间的联系,这与这些系统密切相关。本文还探讨了肠道微生物群与肥胖的联系,特别是厚壁菌门/拟杆菌门比率作为有用生物标志物的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6793/12028513/8780941a0767/medicina-61-00607-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验